Dayanira Alsina-Beauchamp
  • Department of Immunology and Oncology, National Centre of Biotechnology (CNB/CSIC), Campus de Cantoblanco, Spain
  • Cancer Biology
Personal information


Doctorate Biochemistry, Molecular Biology, Biomedicine and Biotechnology, Universidad Autónoma de Madrid, 2015

Current position

FPI grant, Ph.D., Department of Immunology and Oncology, National Research Center (CNB-CSIC), Madrid, Spain


  1. Alsina-Beauchamp, D., Reino, P. d. and Cuenda, A. (2015). Isolation and flow-cytometric analysis of mouse intestinal crypt cells. Bio-protocol 5(21): e1635.
  2. Zur, R., Garcia-Ibanez, L., Nunez-Buiza, A., Aparicio, N., Liappas, G., Escos, A., Risco, A., Page, A., Saiz-Ladera, C., Alsina-Beauchamp, D., Montans, J., Paramio, J. M. and Cuenda, A. (2015). Combined deletion of p38gamma and p38delta reduces skin inflammation and protects from carcinogenesis. Oncotarget 6(15): 12920-12935.
  3. Del Reino, P., Alsina-Beauchamp, D., Escos, A., Cerezo-Guisado, M. I., Risco, A., Aparicio, N., Zur, R., Fernandez-Estevez, M., Collantes, E., Montans, J. and Cuenda, A. (2014). Pro-oncogenic role of alternative p38 mitogen-activated protein kinases p38gamma and p38delta, linking inflammation and cancer in colitis-associated colon cancer. Cancer Res 74(21): 6150-6160.
  4. Criado, G., Risco, A., Alsina-Beauchamp, D., Peréz Lorenzo, M. J., Escós, A. and Cuenda, A. (2013). Alternative p38 mitogen-activated protein kinases are essential for collagen-induced arthritis. Arthritis & Rheumatism 66 (5): 1208-1217.
  5. Risco, A., del Fresno, C., Mambol, A., Alsina-Beauchamp, D., MacKenzie, K. F., Yang, H. T., Barber, D. F., Morcelle, C., Arthur, J. S., Ley, S. C., Ardavin, C. and Cuenda, A. (2012). p38gamma and p38delta kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation. Proc Natl Acad Sci U S A 109(28): 11200-11205.